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ABSTRACT
Charcot-Marie-Tooth (CMT) disease is one of the most common inherited disorders of the peripheral nervous system.
Patients diagnosed with CMT disease have axonal degeneration which results in muscle wasting, sensory loss and
weakness. These patients have a very characteristic walking gait and shape of hands, along with other changes.
Despite many common visible changes, no singular common genetic mutation for this disease or its cure has been
identified. Therefore more case series for this disease needs to be identified so that future studies increase our
knowledge about this disease. Here, we present a case series of 3 out of 4 siblings who have been diagnosed with
CMT disease. Based on their age, these siblings show the different developmental stages of this disease. More of such
case series need to be identified and reported so that we can identify the true genetic cause of this disease and
develop a definitive cure for it.
INTRODUCTION

the hands and forearms are also affected, while the
same pattern evolves to include sensory loss and
reduction of the deep tendon reflexes.
Disease onset is usually in the first two decades and
then there is slow progression over decades. Usually
the presentation includes pes cavus (or pes planus,
often later progressing to cavus deformity); hammer
toes; difficulty in running; twisting of the ankle and
tripping; difficulty in walking; foot drop; steppage gait;
wasting, weakness, and sensory loss of distal segments
of lower and then upper limbs; difficulties in hand
manipulation; and reduced or absent deep-tendon
reflexes7, 8.
Currently there is no treatment available for this
disease. Further studies are required to understand this
rare disease and possibly develop its treatment. The
discovery of more cases is extremely crucial to
understand this disease and better describe its clinical
features. In this case series we describe a family in
which 3 out of 4 siblings have been diagnosed with
CMT disease and are potential candidates for further
investigation.

Charcot-Marie-Tooth (CMT) disease was first described
in 1886 as a peripheral nerve disorder and since then
it is now believed to be one of the most common
inherited disorders of the peripheral nervous system1.
The prevalence of CMT varies significantly across
different countries, from 9.7/100000 in Serbia to
82.3/100000 in Norway2. No study has been published
from Pakistan regarding the prevalence of CMT. The
number of genetic mutations associated with this
disease continues to grow beyond 1000, with over 80
genes involved3. However, the cause of a significant
types of CMT remains unknown. Whatever the origin of
the disorder might be, the final common pathway is
that of axonal degeneration or demyelination involving
mostly the largest and longest nerves4. Secondary
axonal degeneration may lead to disability in
demyelinating CMT and may be primary process in
other.
The axonal degeneration in CMT disease tends to start
in the extremities and then spreads to the proximal
limbs which involve muscle wasting, sensory loss and
weakness5, 6. In the feet it is observed that there are
high arches, hammer toes, muscle wasting and
weakness. Ultimately there is involvement of the leg
and then the lower third of the thigh, producing the
typical distal atrophy of the lower limbs. At this point
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CASE SERIES
A family presented to Aga Khan University Hospital in
May 2018 in which 3 out of 4 siblings had difficulty
walking in a straight line and holding objects. The
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parents of these children were first cousins, however,
nobody else in the family had a history of CMT or any
other type of polyneuropathy. The symptoms of each
patient are described below:

also informed that since this is a genetic disorder, if
they have another child the possibility of having CMT is
much higher in that child than average. Therefore, they
should be very careful before making the decision of
having another child.

CASE 1:

DISCUSSION:

The eldest sibling was a 13 years old male child and
presented with difficulty in walking, foot numbness, and
difficulty performing daily tasks, such as shirt buttoning.
The first of these symptoms, difficulty in walking,
started at the age of 4 years . His birth history was
normal, and early motor milestones were achieved on
time. On examination there was atrophy of thenar and
hypothenar muscles, poor hand grip, high stepping gait,
flat feet deformity and deep tendon reflexes were
diminished, however, sensory examination was normal
and senses of position and vibration were intact (figure
1A and B; Supplementary video 1). No other signs or
symptoms were observed. EMG/NCV study was
suggestive of sensory motor polyneuropathy.

Although CMT disease does not reduce the life
expectancy of patients, it is an extremely debilitating
disease. The symptoms of this disease, specially foot
drop and a high-stepped gait can cause frequent
tripping or falls and reduce the quality of life of patients.
Since the definitive genetic cause of this disease is yet
to be discovered, the treatment options remain very
limited. Large scale drug trails with ascorbic acid have
not shown promising results9. Drug trails in mutant
animal model have shown effective results but these
results were not replicated in human trails.
It is a strange fact that the common deficit found in all
CMT disease patients is axonal degeneration involving
mostly the largest and longest nerves10, yet the number
of genetic mutations associated with CMT is over
10002. Therefore, it is fair to say that the true common
genetic cause remains unidentified. Until this genetic
cause is identified the complete pathology of CMT
cannot be understood and a definitive treatment
cannot be developed.
Here we have reported a case series of 3 siblings (from
a family with 4 children) who have been diagnosed of
CMT disease. The mere fact that the only treatment
which could be advised to them was physical and
occupational therapy shows how restricted our
knowledge about this disease and its treatment is.
More case series of this disease needs to be reported
so that more avenues of research can be identified.

CASE 2:
The next sibling was a 9 years old girl who presented
with complaints of clumsiness in walking and running
and difficulty in holding objects, which had started at
the age of 4 years. Her birth history was normal, and
developmental motor milestones were achieved on
time. On examination there was high steeping gait, flat
feet, and thin legs, wasting of muscles of hand, foot,
and lower leg, with diminished deep tendon reflexes
(figure 1C and D; Supplementary video 1). Sensory
examination was normal. EMG/NCV study was
suggestive of sensory motor polyneuropathy.
CASE 3:

CONCLUSION:

The youngest sibling was a 6 years old boy who
presented with difficulty in walking, which had started
at the age of 5 years. His birth history was normal, and
developmental motor milestones were achieved on
time. On examination there was atrophy of foot and
hand intrinsic muscles with flat feet, and thin legs, and
diminished deep tendon reflexes (figure 1E and F;
Supplementary video 1). Sensory examination was
normal.
The parents were informed that there is no treatment
available that can cure the CMT disease, however, it
has been shown that the physical and occupational
therapy improves the quality of life of these patients.
The parents were also counselled about the importance
of foot care of their children and if required, the
possibility of getting corrective surgery. Parents were
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Charcot-Marie-Tooth is a debilitating disease that
causes difficulty in difficulty in walking, foot drop,
muscle wasting and weakness, along with sensory loss
of distal segments of limbs and reduced or absent
deep-tendon reflexes. No treatment except for physical
and occupation therapy can be prescribed for CMT
patients. Here, we have reported a case series of 3
siblings diagnosed with CMT disease. Identification of
this and other such case series helps us to better
understand this disease and develop treatments for it
by opening new venues for research.
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Charcot-Marie-Tooth Disease. A, B) Pictures of hands
and legs of Patient 1 shows advance stages of muscle
contracture and wasting. C, D) Pictures of hands and
legs of Patient 2 also show advance stages muscle
contracture and wasting. E, F) Pictures of hands and
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